baber/WOPTO huggingface dataset:
Patent JP-H11508847-A (JP)
Title: プラスチックチューブ本体およびその製造方法
IPC: B32B1/00
Filed: 1997-04-30
Abstract: (57)【要約】
本発明は、射出成形法でのチューブプリフォームの製造法からなる。本発明の発明者は、射出成形法でのチューブプリフォームの製造に際して、それらを単層または多層に構成でき、のちの、とくにプリフォームの加熱および圧縮空気による二軸拡張により、一方ではチューブ肩部が工学的ネジ山に必要な強度をもち、他方では、円筒面がチューブに望まれる柔軟性を示すチューブを得ることができることを見出した。
Patent JP-2001514604-A (JP)
Title: 肉の包装方法
IPC: B65B25/06
Filed: 1998-03-11
Abstract: (57)【要約】
包装にカバーを掛けるステーションの前のステーションで、肉の内部の空気、または肉とトレイとの間の空気を除去するステップを含む肉の包装方法。回転コンベアを使用する場合に、このコンベアが追加のステーションを含むことができる。しかし、平行処理により、処理時間を不当に延長しないでも、当然内部に空気を含む食品が入っているパッケージの内部の酸素含有量を低くすることができる。
Patent JP-2001521495-A (JP)
Title: 飲料用液体の単一製剤形のミネラルおよびビタミンの治療用組合わせ
IPC: A61K31/59
Filed: 1998-03-04
Abstract: (57)【要約】
本発明は、組合わせた活性主成分として、金属カルシウムおよび少なくとも１種のビタミンＤからなる、歳とった患者の骨粗しょう症の予防および治療用の組合わせに関する。本発明は、液体水性媒体に分散した実質上当該液体水性媒体に不溶なカルシウム塩；少なくとも１種のビタミンＤ；水性媒体にビタミンＤを溶解するための試薬；および水性媒体の粘度を増し、かつ不溶カルシウム塩をこの水性媒体に均一懸濁液で保持するためのゲル化剤からなることを特徴とする。
Patent JP-2002513537-A (JP)
IPC: H04B14/00
Filed: 1998-05-08
Abstract: A communications system in which a communications channel is defined at least in part by an electromagnetic wave having a carrier frequency and an electric field vector, the extremity or terminus of which traces a non-linear periodic path at a rotation frequency less than the carrier frequency and greater than zero from the perspective of an observer looking into the axis of propagation of the wave. The transmitter of the communications system launches a wave having such characteristics and modulated with information in a suitable manner. The receiver of the communications system is sensitive to the periodic path and rotation frequency. The combination of the periodic path and the carrier frequency provides selectivity that can be used to define multiple communications channels.
Patent MD-20000180-A (MD)
Title: Windmill
Inventor: GRIGOR FIODOR
IPC: F03D3/00
Filed: 2000-10-31
Abstract: he invention relates to devices for wind energy conversion into the electric one and may be used for the production of electric energy. Summary of the invention consists in that the windmill contains an actively reactive wind rotor and Darieus-type blades, placed round the circle of the windmill rotor having a larger radius than the windmill rotor radius, installed onto a common vertical axle, effecting equal rotations of the same direction and forming an integral construction.The result consists in increasing the operation efficiency of the windmill.Claims: 1Fig.: 2
Patent MD-20080288-A (MD)
Inventor: CARAGHEAUR MIHAIL
IPC: G08G1/00
Filed: 2008-12-04
Abstract: Inventia se refera la miscarea coordonata a mijloacelor de transport, si anume la procedee de dirijare optimala a fluxurilor de transport. Procedeul de dirijare optimala a fluxurilor de transport consta in aceea ca soferul introduce in terminalul-interfata coordonatele punctului initial si coordonatele punctului de destinatie ale rutei. Terminalul-interfata transmite la centrul de coordonare a fluxului de transport coordonatele punctului initial si coordonatele punctului de destinatie. Calculatorul centrului de coordonare determina traiectoriile de deplasare posibile, efectueaza analiza solicitarii rutelor de transport, prognozeaza incarcarea rutelor de transport reiesind din numarul de apeluri receptionate si numarul de mijloace de transport, care se deplaseaza pe rutele indicate, transmite la terminalul-interfata al mijlocului de transport traiectoria si viteza recomandata.
Patent MX-162193-A (MX)
Inventor: CHU NAN SHIEH
IPC: C08F2/32
Filed: 1982-09-13
Abstract: Water soluble ter- or higher polymer water-in-oil emulsions comprising: (a) an aqueous phase comprising from about 60 to about 80 weight percent and containing therein from about 30 to about 70 weight pecent of a ter- or higher polymer and from about 30 to about 70 weight percent of water, (b) a hydrophobic liquid comprising from about 15 to about 39.5 weight percent, and (c) an oil-soluble surfactant comprising from about 0.5 to about 5 weight percent, said weight percents based on the total weight of the emulsion. The water-in-oil emulsion may be inverted into aqueous systems wherein the polymer is released.
Patent NZ-211970-A (NZ)
Title: Injection moulding of phonograph records
Inventor: AMORY H
IPC: B29C45/26
Filed: 1985-05-03
Abstract: Two matrices (10, 11), each bearing modulation to form a microgroove disc record, are fixed to half-moulds (4) by means of sleeves (23, 24) having first and second fixing flanges (41, 42) which extend into the gap between the matrices. One of the flanges (46) is an annular blade whose inner radial surface (47) defines the edge of a moulded disc and whose thickness is slightly less than that of the moulded disc. Formed integrally with, or attached to, the blade is a group of radially outwardly extending lugs (49) which are attached to the body of its associated sleeve 23. The other flange comprises a second group of lugs (42) mounted to the body of its associated sleeve (24) radially outward of the blade such that the second group of lugs (42) may lie in the spaces between the first mentioned group of lugs (49). The thickness of the lugs (42) of the second group determines the thickness of the disc and the thickness of the lugs of the first and second groups differs, to determine a gap for escape of air along the first flange (41). Spaces between the groups of the two interlaced lugs (49, 42) permit a controlled escape of air from the periphery of the record without the formation of peripheral flash.
Patent NZ-212796-A (NZ)
Title: Pharmaceutical compositions containing xanthine derivatives and o-acetylsalicylic acid
Inventor: WEITHMANN K U
IPC: A61P7/02
Filed: 1985-07-19
Abstract: A combination product containing (A) on the one hand a xanthine derivative of the formula    <IMAGE>  (I)  in which one of the radicals R1 and R3 represents a straight-chain alkyl, ( omega -1)-oxoalkyl or ( omega -1)-hydroxyalkyl group having 3 to 8 carbon atoms, and the two other radicals R2 and R3, or R1 and R2 represent straight-chain or branched alkyl groups having 1 to 8 carbon atoms in the position of R1 and R3 and 1 to 4 carbon atoms in the position of R2, the maximum total of carbon atoms in these two alkyl substituents being 10, or of the formula    <IMAGE> (II)  in which R represents an alkyl radical having 1 to 4 carbon atoms, or prodrug forms of the oxoalkylxanthines of the formula I and II or of the hydroxyalkylxanthine of the formula I, or its metabolites, and (B) on the other hand O-acetylsalicyclic acid or its pharmacologically tolerated salts, (C) with or without a pharmaceutical vehicle, for sequential administration in the treatment of diseases caused or characterized by impaired constituents of blood, in particular platelets or erythrocytes, but also leukocytes, in such a manner that component (A) is released first, and its use in human and veterinary medicine.
Patent NZ-236163-A (NZ)
Title: Continuously producing an elongate element from mixture of waste plastics and filling materials
Inventor: ANDERSSON CURT
IPC: B29C48/92
Filed: 1990-11-20
Abstract: A method and apparatus for producing an elongated beam from compressible material. A mixture of filling material and plastic material is delivered to a first space and there compressed. The compressed material is pressed through a nozzle into a second space defined by a matrix of wall parts, where the material is made more rigid. The wall parts of the matrix can be moved backwards and forwards in a particular sequence to enable beam parts to be fed continuously through the matrix.
Patent NZ-264518-A (NZ)
Title: Recombinant raccoon poxvirus containing genes for the nucleocapsid and/or transmembrane proteins of feline infectious peritonitis virus (fipv)
Inventor: WASMOEN TERRI
IPC: C12N7/00
Filed: 1994-09-22
Abstract: The invention that relates to recombinant raccoon poxvirus useful as a Vaccine Against Feline Infectious Peritonitis Virus Disease. The recombinant raccoon poxvirus has at least one internal gene comprising a DNA sequence encoding a member selected from the group consisting of the nucleocapsid (N) and transmembrane (M/E1) proteins of Feline Infectious Peritonitis Virus (FIPV).
Patent NZ-272183-A (NZ)
Title: Suspended ceiling construction comprises a connector for a suspended ceiling grid that provides a first end lock in a non re-entrant slot and a lock with an identical opposed connector
Inventor: KOSKI GERALD LEE
IPC: E04C2/42
Filed: 1995-05-23
Abstract: A connector (19) for suspended ceiling grid that provides a first end lock in a main tee slot (18) and a lock with an identical opposed connector (19). The connector (19) in the first end lock and in the connector-to-connector lock is installed with a simple stab-in motion. The connector works with a non-re-entrant slot profile that avoids the risk of improper assembly. The connector is releasable without tools and is reusable. The connector emits an audible click when fully installed, is resistant to damage from rough handling, and affords high tensile and compressive strength in its connections.
Patent NZ-274386-A (NZ)
Title: Safety razor; details relating to the blades in a three-bladed unit
Inventor: GILDER BERNARD
IPC: B26B21/22
Filed: 1994-09-22
Abstract: The safety razor blade unit comprises a guard, a cap and a group of three blades with parallel sharpened edges located in between the guard and cap. The first blade (11) defines the edge nearest the guard and has an exposure not greater than zero, while the third blade (13) defining the edge nearest the cap has an exposure not less than zero. The exposure of the first blade has a negative value of -0.04 mm,, and the span between the first blade edge and the guard is in the range of 0.5 mm to 1.5 mm. The span between the edge of the third blade and the edge of the second blade is in the range of 1.0 to 2.0 mm.
Patent NZ-323973-A (NZ)
Title: Vaccine compositions for intranasal administration comprising chitosan and use thereof
Inventor: ILLUM LISBETH
IPC: A61K31/00
Filed: 1996-12-09
Abstract: A vaccine composition adapted for intranasal administration, which composition comprises antigen and an effective adjuvant amount of a chitosan, with the proviso that said antigen is not an influenza virus antigen. Also disclosed is the use of an antigen and chitosan in the manufacture of a medicament for enhancing the immune response of a patient in need thereof, with the proviso that said antigen is not an influenza virus antigen.
Patent NZ-331369-A (NZ)
Title: Use of a genetic construct that directs virus expression in a lymphoid organ or a transduced cell thereof for genetic immunization
Inventor: LISZIEWICZ JULIANNA
IPC: C07K14/16
Filed: 1997-02-20
Abstract: A genetic construct that encodes a virus in a host's lymphoid organ or of a cell transduced with the genetic construct is used in the manufacture of a medicament for raising an immune response in the host. The virus can be a Class 4 virus or a retrovirus.  The construct can also be capable of transducing the cell to express a cytokine to augment or direct the host's immune response or to express a tumour antigen. A pharmaceutical composition comprises a cell that has been transduced with a genetic construct that encodes a Class 4 virus.
Patent NZ-335549-A (NZ)
Title: Use of a notch-ligand for affecting infectious tolerance and in the manufacture of a medicament for immunotherapy
Inventor: LAMB JONATHON ROBERT
IPC: A61P33/00
Filed: 1997-11-06
Abstract: The use of therapeutic compounds in the modification of T-cell, T-cell antigen presenting cell (APC) interactions and the interactions between pathogenic organisms and immunocompetent cells of a host, specifically modulating the interaction between Notch protein family members and their ligands, Delta and Serrate.  The therapeutic compounds will be useful when a T-cell mediated disease or infection is due to an allergy, autoimmunity, graft rejection, tumor induced aberrations to the T-cell system, and infectious diseases such as those caused by Plasmodium species, Microfilariae, Helminths, Mycobacteria, HIV, Cytomegalovirus, Pseudomonas, Taxoplasma, Echinococcus, Haemophilus, influenza type B, measles, Hepatitus C or Toxicara.
Patent NZ-335800-A (NZ)
Title: Teat cup liner having fluted lower portion with no flutes on upper shoulder
Inventor: SANFORD SCOTT A
IPC: A01J5/08
Filed: 1999-05-17
Abstract: The teatcup liner has an elongated, flexible, generally tubular liner (104) extending along a longitudinal axis 105.  The liner has an upper section (106) for mounting to a teatcup, a mouthpiece chamber (107) having a shoulder (108) below the upper section, and a barrel (110) below the shoulder.  The barrel has alternating exterior and interior axially extending  flutes (112) and (114).  The mouthpiece chamber shoulder is fluteless along both its exterior (116) and interior (118)
Patent NZ-505801-A (NZ)
Title: Liquid crystal display (LCD) with a second layer of liquid crystal designed to selectively block or diffuse light
Inventor: WITEHIRA PITA
IPC: G02B27/22
Filed: 1999-02-23
Abstract: A device that selectively diffuses light for use as an independent display or in conjuncture with multileveled imaging systems is disclosed. The device comprises a layer which incorporates liquid crystal material between random homogenous alignment layer(s) with a method of applying an electric field to such liquid crystal, with said device being placed at a distance from a transmissive display device, to selectively block polarized light from reaching an LCD layer in the said multilayer display.
Patent NZ-507934-A (NZ)
Title: Composition containing vitamin K and a carrier
Inventor: LEECH WAYNE FREDERICK
IPC: A61K31/12
Filed: 2000-11-02
Abstract: A vitamin K composition contains: 0.001 to 50% by weight of one or more vitamin K compounds or analogues; 0.1-25% by weight of polyethylene hydroxy stearate; 0-50% by weight of propylene glycol; 0-50% by weight of benzyl alcohol and 0-90% by weight of water and/or alcohol; wherein the other excipients are added to a total of 100% by weight. The composition is used to treat anticoagulant poisoning.
Patent NZ-508095-A (NZ)
Title: Method and apparatus for mulching waste with the addition of moisture
Inventor: ROPER MAXWELL
IPC: C05F17/00
Filed: 1999-05-12
Abstract: Method and apparatus for processing green organic waste (hereafter "GOM") into mulch particles for forming a mulch windrow including feeding means (11) for feeding GOM to a first cutting zone and rotating a plurality of blades (25) through that zone to cut the GOM into smaller particles, transferring the particles to a second cutting zone and rotating a plurality of blades (25) therethrough, to reduce their size to a suitable mulch particle size and ejecting the mulch particles at high velocity to form a windrow. The method and apparatus further includes the addition of moisture to increase the moisture content of the windrow formed.
Patent NZ-509613-A (NZ)
Title: Cable, for telecommunications, with even number of paired conductors evenly divided into groups of at least two conductor pairs, with even number surrounding additional pair of conductors encircled around filler material
Inventor: TOTLAND RUNE
IPC: H01B11/04
Filed: 1999-08-06
Abstract: A cable that includes an even number of paired couples of conductors, evenly divided into groups, and an additional couple of conductors, coupled with and encircled around a length of a filler material, extended in parallel so the groups of conductor pairs surround the additional pair of conductors and the filler material and surrounded by a jacket material, and a method for forming the cable.
Patent NZ-510147-A (NZ)
Title: Selection method
Inventor: JORSBOE MORTEN
IPC: C12N15/64
Filed: 1999-08-11
Abstract: A selection method for selecting from a population of cells one or more selectable genetically transformed cells wherein the population of cells comprises selectable genetically transformed cells and optionally non-transformed cells wherein the selectable genetically transformed cells comprises a first expressable nucleotide sequence encoding a first expression product; and optionally a second expressable nucleotide sequence encoding a second expression product and/or a third expressable nucleotide sequence encoding a third expression product, a component is detoxifiable by the selectable genetically transformed cells by action of the first expressable nucleotide sequence or the first expression product and optionally by the action of the optional second expressable nucleotide sequence or the optional second expression product and/or by the action of the optional third expressable nucleotide sequence of the optional third expression product wherein the component can be present in an amount that is toxic to the non-transformed cells; the method comprising introducing the population of cells to a culture medium comprising the component wherein the component is galactose.
Patent NZ-516064-A (NZ)
Title: Detachment surface
Inventor: SHORT ROBERT
IPC: C12N5/071
Filed: 2000-06-23
Abstract: A therapeutic vehicle for use in tissue engineering wherein said vehicle has a cell culture surface obtained by plasma polymerization, to which at least one cell can reversibly attach characterised in that the surface contains an aid functionality of at least 5%.
Patent NZ-524938-A (NZ)
Title: Dispenser, for treating animals, with damping to avoid shock waves
Inventor: WARD NEIL BARRY
IPC: A61M5/315
Filed: 2003-03-24
Abstract: A dispensing apparatus 100 includes a barrel 1 and a plunger 2. A head 2A of the plunger 2 and an inner wall 1A of the barrel 1 together define a chamber 3 of variable volume. The apparatus 100 has a fluid inlet valve 10 operable to allow fluid to flow into the chamber 3 when the volume of the chamber increases and at least one fluid outlet valve 12 to allow fluid to flow out of the chamber 3 when volume decreases. A biasing means 9 biases the plunger 2 towards a first position and a plunger means 4 is operable to actuate the plunger 2 towards a second position. The apparatus 100 has plunger damping means 14 to decelerate the plunger 2 when the plunger 2 is moving towards the first position but before the plunger 2 reaches the first position.
Patent NZ-526020-A (NZ)
Title: Press fabric
Inventor: JOYCE MICHAEL J
IPC: D21F7/08
Filed: 2001-11-27
Abstract: The present invention is directed to a press fabric (10) having an anti-rewet scrim or "barrier" (16) with the internal structure of a press fabric, and a method for making same. External materials are not necessary in creating the barrier, i.e. the existing material is modified to create a natural barrier to prevent water migration back to the press fabric surface.
Patent NZ-532385-A (NZ)
Title: Methods of preventing and treating flavivirus infection in animals
Inventor: MONATH THOMAS P
IPC: C12N15/33
Filed: 2002-10-21
Abstract: A method for preventing or treating flavivirus infection in a non-human animal, excluding laboratory animals, comprises administrating a chimeric flavivirus. Preferably the infection is a West Nile virus infection, the chimeric flavivirus comprises the capsid and non-structural protein of a yellow fever virus and the prM and envelope proteins of West Nile virus and the animal is a horse.
Patent NZ-533599-A (NZ)
Title: Isolated peptides, or nucleic acids encoding the same, that are CRF, urocortin I, urocortin II, urocortin III, sauvagine, urotensin I or related peptide derivatives
Inventor: ISFORT ROBERT JOSEPH
IPC: A61P21/00
Filed: 2003-01-16
Abstract: Described are isolated corticotrophin releasing factor derivatives, and nucleic acids encoding the same. These derivatives are effective for treating corticotrophin releasing factor 2 receptor modulated disorders such as muscular dystrophy.
Patent NZ-537723-A (NZ)
Title: Combinations of cyclohexanedione oxime herbicides and safeners
Inventor: HACKER ERWIN
IPC: A01N37/08
Filed: 2003-07-07
Abstract: Disclosed is a herbicide-safener combination which comprises: One or more herbicidal cyclohexanedione oximes ("dims") or an agriculturally acceptable salt or metal complex thereof, selected from the group consisting of: alloxydim, butroxydim, clefoxydim, clethodim, cycloxydim, sethoxydim, tepraloxydim and tralkoxydim. And an antidotally effective amount of one or more compounds of formula (I) or a salt thereof in which: Each R1 is identical or different and is halogen or (C1-C4)-haloalkyl; n is an integer from 1 to 3; R2 is H, alkyl, alkoxy-alkyl, cycloalkyl, tri-alkyl-silyl or tri-alkyl-silylmethyl; R3 is H, alkyl, haloalkyl, alkenyl, alkynyl or cycloalkyl; and R4 is H or alkyl.
Patent NZ-538411-A (NZ)
Title: Continuous emulsification process for heating and emulsifying processed cheese in which the accurate viscosity measured inline is obtained and production conditions are controlled automatically
Inventor: SHIDARA HIDEO
IPC: A01J25/00
Filed: 2004-07-05
Abstract: Described are a method and device for continuously emulsifying process cheese or the like with a viscosity accurately measured on-line while automatically controlling the production condition. A method and apparatus for continuously producing process cheese or the like is also disclosed. In this method, the material of the process cheese or the like is heated in a vessel (3) given a predetermined pressure, agitated and emulsified with an arbitrary agitation strength by means of an agitator (4), made to flow for a predetermined time through a holding pipe (7), cooled, formed, and packed, thereby producing a process cheese product (13) or the like. A vibrator of a vibration viscometer (10) is buried in the held or cooled process cheese or the like without direct contact with the process cheese. The agitation strength of the agitator and/or the back pressure in the vessel are regulated so that the detection value detected by the vibrator may approach a preset target value. Thus automatic control is conducted so that the viscosity of the process cheese during the holding or after the cooling may approach a target value.
Patent NZ-544719-A (NZ)
Title: Combination of mGluR2 antagonist and aChE inhibitor for treatment of acute and/or chronic neurological disorders
Inventor: BALLARD THERESA MARIA
IPC: A61K31/551
Filed: 2004-07-17
Abstract: Disclosed is the use of an AChE inhibitor and a mGluR2 antagonist in the manufacture of a medicament for preventing or treating an acute and/or chronic neurological disorder.
Patent NZ-546009-A (NZ)
Title: Method and composition for preventing multiple organ dysfunction syndrome
Inventor: VAN HOORN EDUARD CHRISTIAAN
IPC: A23L33/00
Filed: 2004-09-20
Abstract: Disclosed is the use of a liver guanosine-5Æ-triphosphate (GTP) increasing component in the manufacture of a medicament for use in a method of preventing multiple organ dysfunction in a mammal suffering from trauma, said method comprising enterally administering to said mammal, within 24 hours of the occurrence of the trauma, (i) the medicament comprising the liver GTP increasing component selected from the group consisting of :2-2000 mg guanosine equivalents; 0.5-40 g ribose equivalents; and combinations thereof and (ii) at least 20g of digestible water soluble carbohydrates in the form of an aqueous liquid composition containing at least 10 g/l of said digestible water soluble carbohydrates. Also disclosed is an aqueous liquid composition suitable for enteral administration containing 20-200g/l digestible dissolved carbohydrates, 5-5000 mg/l guanosine equivalents; at least one of 1-100 g/l ribose equivalents and 2-2000 mg/l flavonoids; and 45 to 97.95 wt. % water/